Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K, Kamijima S, Enomoto T. , Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database. , Journal of Gynecolgic Oncology , Nov;33(6):e78 ,  2022/9/30 , https://doi.org/10.3802/jgo.2022.33.e78